Skip To Main Content
Xiuying Zhang on Muck Rack

Xiuying Zhang

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, Taylor & Francis Online, ACS Publications, Nutrition & Metabolism, Royal Society of Chemistry, BioRxiv, Dove Medical Press and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiuying

Contact Xiuying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes

|
By Wei Zhao, Lingli Zhou, Ying Gao, Xianghai Zhou, Xueyao Han, Xiuying Zhang, Linong Ji
| Frontiers
Abstract Background: Insulin-like growth factor-1 (IGF-1) receptor (IGF-1R) inhibitors have changed the treatment landscape for moderate-to-severe thyroid eye disease (TED), but the longitudinal behavior of circulating IGF-1 during and after therapy remains insufficiently characterized. This study aimed to describe serum IGF-1 dynamics in patients with TED treated with IGF-1R inhibitor teprotumumab N01 and to explore their relationship with glycemic changes.
Open in Who Shared Issue with article?

Mechanistic Insights into Maxing Shigan Decoction in Community-Acquired Pneumonia Based on Bioinformatics and Experimental Validation

|
By Chenhao Wei, Rui Wang, Xiuying Zhang
| Dove Medical Press
Back to Journals » Infection and Drug Resistance » Volume 19 Authors Wei C , Wang R, Zhang X , Yang M, Zhang S, Zhao H, Zhang L Received 3 July 2026 Accepted for publication 27 August 2026 Published 5 September 2026 Volume 2026:19 637858 DOI https://doi.org/10.2147/IDR.S637858 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Hazrat Bilal Chenhao Wei,1,* Rui Wang,1,* Xiuying Zhang,2 Mengfei Yang,1 Shiyao...
Open in Who Shared Issue with article?

PGC-1α protects against MASH via Tim23-dependent inhibition of DRP1-mediated ferroptosis - Cell Death & Disease

|
By Yanmian Zhao, Linzhong Zhang, Bairong Li, Menghan Liu, Yanting Zhang, Shoubin Ning, Xiuying Zhang
| Nature Verified
Abstract Peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α) is crucial for mitochondrial function and biogenesis. However, whether and how PGC-1α can regulate hepatocyte ferroptosis during the pathogenic process of metabolic dysfunction-associated steatohepatitis (MASH) has not been clarified. Hepatocyte ferroptosis was assessed in the liver of MASH patients and in vivo and in vitro MASH models.
Open in Who Shared Issue with article?
See all 25 licensed articles (26 Total)